A Copayment Increase for Prescription Drugs: The Long-Term and Short-Term Effects on Use and Expenditures
Open Access
- 1 August 2005
- journal article
- research article
- Published by SAGE Publications in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
- Vol. 42 (3) , 293-310
- https://doi.org/10.5034/inquiryjrnl_42.3.293
Abstract
This study estimates the effects of an increase in an outpatient prescription drug copayment using a natural experiment based upon a large firm that implemented such an increase. The findings suggest that the primary effect of a copayment increase is attenuation of the trend in prescription drug utilization. We also find an initial reduction in expenditures, with the effects on spending diminishing. Employees with an existing chronic illness and those without a chronic illness show a similar, inelastic response to a copayment increase; employees with a newly diagnosed chronic illness have a more inelastic response.Keywords
This publication has 32 references indexed in Scilit:
- Three-Tiered–Copayment Drug Coverage and Use of Nonsteroidal Anti-inflammatory DrugsArchives of internal medicine (1960), 2004
- Pharmacy Benefits and the Use of Drugs by the Chronically IllJAMA, 2004
- Too much ado about two-part models and transformation?Journal of Health Economics, 2004
- How Much Should We Trust Differences-In-Differences Estimates?The Quarterly Journal of Economics, 2004
- Interaction terms in logit and probit modelsEconomics Letters, 2003
- The U.S. Pharmaceutical Industry: Why Major Growth In Times Of Cost Containment?Health Affairs, 2001
- Explaining Drug Spending Trends: Does Perception Match Reality?Health Affairs, 2000
- METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTSAnnual Review of Public Health, 1999
- Regression Analysis of Count DataPublished by Cambridge University Press (CUP) ,1998
- Staging of DiseaseJAMA, 1984